Product Information
E.E.S. 200 MG/5 ML SUSPENSION is a brand product labeled by Carnegie Pharmaceuticals LLC, priced at $3.6046 per ML under NDC 80005015218. Its NADAC has been published 2 times since Apr 9, 2025.
Strength
200 mg/5mL
Manufacturer
Carnegie Pharmaceuticals LLCNDC
80005015218
Classification
Brand
Dosage Form
GRANULE, FOR SUSPENSION
Route
ORAL
Last Updated
4/9/2025
Active Ingredients
ERYTHROMYCIN ETHYLSUCCINATEApproval Type
New Drug (NDA)
FDA Application
NDA050207On Market Since
1/15/2025
Pharmacological Classes
Price Statistics
The NADAC for E.E.S. 200 MG/5 ML SUSPENSION has been published 2 times since Apr 9, 2025, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $3.6046 per ML |
|---|---|
| All-time high | $3.6046 (Apr 16, 2025) |
| All-time low | $3.6046 (Apr 9, 2025) |
| Median price | $3.6046 |
| Average price | $3.6046 |
| Largest weekly change | 0.0% (Apr 16, 2025) |
| Weeks tracked | 2 |
| Tracking since | Apr 9, 2025 |
Generic Alternatives
The matcher finds 4 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 4 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 75% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of E.E.S. 200 MG/5 ML SUSPENSION?
The current National Average Drug Acquisition Cost (NADAC) for E.E.S. 200 MG/5 ML SUSPENSION, manufactured by Carnegie Pharmaceuticals LLC, is $3.6046 per ML (NDC 80005015218), effective Apr 16, 2025.
How has the price of E.E.S. 200 MG/5 ML SUSPENSION changed over time?
Over the history we have for it, the NADAC for E.E.S. 200 MG/5 ML SUSPENSION has held within roughly two percent of its current level. It has been tracked across 2 weekly CMS publications since Apr 9, 2025.
What are the highest and lowest recorded NADAC prices for E.E.S. 200 MG/5 ML SUSPENSION?
Since Apr 9, 2025, the NADAC for E.E.S. 200 MG/5 ML SUSPENSION has ranged from a low of $3.6046 (Apr 9, 2025) to a high of $3.6046 (Apr 16, 2025), with a median of $3.6046 per ML.
Are there cheaper alternatives to E.E.S. 200 MG/5 ML SUSPENSION?
Yes. 4 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, ERYTHROMYCIN 200 MG/5 ML SUSP, is $0.9048 per ML — about 75% below E.E.S. 200 MG/5 ML SUSPENSION.
Who manufactures E.E.S. 200 MG/5 ML SUSPENSION?
E.E.S. 200 MG/5 ML SUSPENSION (NDC 80005015218) is labeled by Carnegie Pharmaceuticals LLC, and CMS classifies it as a brand product.
Related Drugs
Same classification